Filing Details
- Accession Number:
- 0001217234-21-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-15 17:21:05
- Reporting Period:
- 2021-01-14
- Accepted Time:
- 2021-01-15 17:21:05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1217234 | Caredx Inc. | CDNA | Services-Medical Laboratories (8071) | 943316839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1721150 | Sasha King | C/O Caredx, Inc. 1 Tower Place, 9Th Floor South San Francisco CA 94080 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-01-14 | 833 | $1.07 | 44,264 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-14 | 2,500 | $5.90 | 46,764 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-14 | 417 | $2.80 | 47,181 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-14 | 750 | $1.00 | 47,931 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-14 | 3,125 | $12.24 | 51,056 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-14 | 1,250 | $6.31 | 52,306 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2021-01-14 | 1,000 | $27.17 | 53,306 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-01-14 | 700 | $85.24 | 52,606 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-14 | 1,400 | $86.46 | 51,206 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-14 | 2,601 | $87.56 | 48,605 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-14 | 5,174 | $88.16 | 43,431 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 833 | $0.00 | 833 | $1.07 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 2,500 | $0.00 | 2,500 | $5.90 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 417 | $0.00 | 417 | $2.80 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 750 | $0.00 | 750 | $1.00 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 3,125 | $0.00 | 3,125 | $12.24 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 1,250 | $0.00 | 1,250 | $6.31 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2021-01-14 | 1,000 | $0.00 | 1,000 | $27.17 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,042 | 2027-06-09 | No | 4 | M | Direct | |
8,333 | 2027-10-27 | No | 4 | M | Direct | |
1,111 | 2027-09-01 | No | 4 | M | Direct | |
750 | 2027-04-21 | No | 4 | M | Direct | |
17,708 | 2028-06-29 | No | 4 | M | Direct | |
5,417 | 2028-01-19 | No | 4 | M | Direct | |
8,333 | 2029-02-04 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.76 to $85.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $85.99 to $86.915, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $87.06 to $88.03, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $88.06 to $88.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
- 25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
- 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
- 50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
- 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.
- 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
- 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
- 1/4th of the shares subject to the option vested on February 4, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.